Austria: The Current Status of Maintenance Treatment in Schizophrenia

  • W. W. Fleischhacker
  • U. Meise

Abstract

Psychiatric hospitals in Austria have about 10000 beds for acute and chronic patients. We estimate that schizophrenic patients are responsible for about 20% of all acute hospital admissions, while the percentage of schizophrenics in long-stay units probably exceeds 30%. Twenty-nine neuroleptics of the various chemical classes are currently registered and marketed in Austria. Four of these (haloperidol, fluphenazine, flupenthixol and clopenthixol) are available in long-acting injectible depot preparations; one (penfluridol) is a long-acting oral antipsychotic.

Keywords

Schizophrenia Haloperidol Clozapine Decanoate Thioridazine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • W. W. Fleischhacker
  • U. Meise

There are no affiliations available

Personalised recommendations